New drug aims to boost height in kids with dwarfism

NCT ID NCT07441876

First seen Apr 07, 2026 · Last updated May 15, 2026 · Updated 9 times

Summary

This study tests a new medicine called BMN 333 against an existing drug (vosoritide) to see which works better for helping children with achondroplasia grow taller. About 160 children ages 2 to 17 will take part. The goal is to measure how fast they grow over one year and check for side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACHONDROPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Consano Clinical Research, LLC

    RECRUITING

    California City, California, 78231, United States

    Contact

  • Murdoch Children's Research Institute

    RECRUITING

    Parkville, Victoria, 3052, Australia

    Contact

  • Texas Children Hospital, Baylor College of Medicine, Houston TX

    RECRUITING

    Houston, Texas, 77030, United States

    Contact

  • UCSF Benioff Children's Hospital Oakland

    RECRUITING

    Oakland, California, 94609, United States

    Contact

Conditions

Explore the condition pages connected to this study.